CAPRICOR THERAPEUTICS, INC. Restricted Cash and Cash Equivalents
CAPRICOR THERAPEUTICS, INC. (CAPR) had Restricted Cash and Cash Equivalents of $0 as of 2020-09-30, per its 10-Q filed 2020-11-13.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2020-11-13
- 2020-09-30: Restricted Cash and Cash Equivalents $0.00.
- 2020-06-30: Restricted Cash and Cash Equivalents $0.00.
- 2020-03-31: Restricted Cash and Cash Equivalents $0.00.
- 2019-12-31: Restricted Cash and Cash Equivalents $0.00.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2020-09-30 | $0.00 10-Q · filed 2020-11-13 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-15 |
| 2019-12-31 | $0.00 10-K · filed 2020-03-27 |
| 2019-06-30 | $200.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $200.00K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $300.00K 10-Q · filed 2019-08-08 |
| 2018-09-30 | $400.00K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $500.00K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $600.00K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $700.00K 10-K · filed 2019-03-29 |
| 2017-09-30 | $600.00K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $800.00K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $1.10M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $1.30M 10-K · filed 2018-03-22 |
| 2016-09-30 | $600.00K 10-Q · filed 2016-11-14 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |